iSpecimen to Participate in the H.C. Wainwright BioConnect Conference on January 10-13, 2022

On January 4, 2022 iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, reported that Christopher Ianelli, MD, PhD, CEO and President of iSpecimen, will participate in the H.C. Wainwright BioConnect Conference to be held virtually on January 10-13, 2022 (Press release, iSpecimen, JAN 4, 2022, https://www.prnewswire.com/news-releases/ispecimen-to-participate-in-the-hc-wainwright-bioconnect-conference-on-january-10-13-2022-301453120.html [SID1234598149]). Dr. Ianelli’s corporate presentation will be available on-demand starting Monday, January 10th at 7:00 a.m. ET.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

For more information about the H.C. Wainwright BioConnect Conference, or to schedule a one-on-one meeting with iSpecimen’s management, please contact your H.C. Wainwright representative directly or KCSA Strategic Communications at [email protected].